- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05240027
To Vape or Not to Vape
May 24, 2022 updated by: Methodist Health System
The overall goal of this study is to increase knowledge of vaping and its associated risks.
This study will find the patterns of vaping, and how it all started among adolescents.
Investigators want to know if students are aware of the serious and long term effects of vaping.
This program titled, "To Vape or Not to Vape", will provide education to adolescents and young adults about the potential risk of vaping in an effort to assist with lowering the usage rates within the population.
Content will include information about current statistics, potential short-term and long-term side-effects, and healthy alternatives for dealing with stress and peer-pressure.
Investigators anticipate that this program will increase this population's knowledge about the risks of vaping products, and deter them from future use of the products.
Effectiveness of this program will be measured by pre and post-tests.
Investigators believe this program will make at least 50 percent of the participants more aware of the dangers and consequences of vaping, potentially lowering the rates of those participating in this habit while also preventing others from starting.
Study Overview
Detailed Description
The overall goal of this study is to increase knowledge of vaping and its associated risks.
This study will find the patterns of vaping, and how it all started among adolescents.
Investigators want to know if students are aware of the serious and long term effects of vaping.
This program titled, "To Vape or Not to Vape", will provide education to adolescents and young adults about the potential risk of vaping in an effort to assist with lowering the usage rates within the population.
Content will include information about current statistics, potential short-term and long-term side-effects, and healthy alternatives for dealing with stress and peer-pressure.
Investigators anticipate that this program will increase this population's knowledge about the risks of vaping products, and deter them from future use of the products.
Effectiveness of this program will be measured by pre and post-tests.
Study Type
Interventional
Enrollment (Actual)
363
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75203
- Methodist Dallas Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The program's targeted population is starting at the middle school grade levels, up to college.
- Live in the DFW metroplex
- Willing to participate throughout the presentation
Exclusion Criteria:
- Less than 12 years old
- Students that are not in the DFW metroplex
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Middle, High and College students within the Dallas-Fort Worth area that may Vape
The program will be going to middle school, high school, and college campuses in the Dallas-Fort Worth (DFW) area to speak with students about vaping.
The program will be implemented by community outreach, as the students will be presented with information about vaping and the resources necessary to prevent or stop vaping.
|
pre & post test surveys
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
percentage of vape users
Time Frame: The program will last 5 months between March 2020 and August 2020.
|
Investigators will obtain the percentage of vape users and their reasons for vaping from information gathered from (per-test questionnaire).
|
The program will last 5 months between March 2020 and August 2020.
|
reasons for vaping
Time Frame: The program will last 5 months between March 2020 and August 2020.
|
Investigators will obtain the percentage of vape users and their reasons for vaping from information gathered from (per-test questionnaire).
|
The program will last 5 months between March 2020 and August 2020.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Educational Effectiveness
Time Frame: The program will last 5 months between March 2020 and August 2020.
|
Changes in the degree of understanding will be assessed from the results of the pre and post-test (questionnaire).
|
The program will last 5 months between March 2020 and August 2020.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maiya Bangurah, MBA, Methodist Health System Clinical Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 13, 2020
Primary Completion (Actual)
February 26, 2021
Study Completion (Actual)
February 26, 2021
Study Registration Dates
First Submitted
November 9, 2021
First Submitted That Met QC Criteria
February 3, 2022
First Posted (Actual)
February 15, 2022
Study Record Updates
Last Update Posted (Actual)
May 31, 2022
Last Update Submitted That Met QC Criteria
May 24, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 009.ONC.2020.D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaping
-
Philip Morris Products S.A.CompletedNicotine | Nicotine Vaping | VapingUnited Kingdom
-
St. Jude Children's Research HospitalRecruitingVaping | Vaping CessationUnited States
-
University of Massachusetts, WorcesterNational Cancer Institute (NCI)Not yet recruiting
-
University of RochesterNational Cancer Institute (NCI)Completed
-
UNC Lineberger Comprehensive Cancer CenterNational Institute on Drug Abuse (NIDA); Food and Drug Administration (FDA)Recruiting
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)Recruiting
-
Philip Morris Products S.A.CompletedNicotine | Nicotine Vaping | VapingUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Food and...Completed
-
Mayo ClinicWithdrawn
-
Clemson UniversityUniversity of VermontCompleted
Clinical Trials on Vape use survey
-
University of AarhusAarhus University HospitalCompletedElectronic Cigarette Use | Lung Function | Second Hand SmokeDenmark
-
Pivot Health Technologies Inc.Active, not recruiting
-
Philip Morris Products S.A.Terminated
-
Philip Morris Products S.A.Terminated
-
Philip Morris Products S.A.Terminated
-
University of VermontNational Institute on Drug Abuse (NIDA)Completed
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaboratorsCompletedCardiovascular Diseases | Tobacco Use | Pulmonary Disease | E-Cigarette UseUnited States
-
Centre Hospitalier Princesse GraceAssociation de Recherche Bibliographique pour les NeurosciencesCompletedParkinson Disease(PD) | Alzheimer's Dementia | Fronto-Temporal Dementia
-
Roswell Park Cancer InstituteNational Institute on Drug Abuse (NIDA)Not yet recruitingCigarette Smoking-Related Carcinoma
-
University of Southern DenmarkRegion Capital Denmark; Region Zealand; North Denmark RegionCompletedResponse | Non-responseDenmark